Stocks and InvestingStocks and Investing
Tue, April 19, 2022
Mon, April 18, 2022
Sun, April 17, 2022
Thu, April 14, 2022
Wed, April 13, 2022

Matthew Sykes Maintained (TWST) at Hold with Decreased Target to $55 on, Apr 13th, 2022


Published on 2024-10-27 20:26:40 - WOPRAI, Matthew Sykes
  Print publication without navigation


Matthew Sykes of Goldman Sachs, Maintained "Twist Bioscience Corporation" (TWST) at Hold with Decreased Target from $105 to $55 on, Apr 13th, 2022.

Matthew has made no other calls on TWST in the last 4 months.



There are 2 other peers that have a rating on TWST. Out of the 2 peers that are also analyzing TWST, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Puneet Souda of "SVB Leerink" Maintained at Hold with Decreased Target to $70 on, Monday, February 7th, 2022


This is the rating of the analyst that currently disagrees with Matthew


  • Luke Sergott of "Barclays" Maintained at Buy with Decreased Target to $75 on, Monday, February 7th, 2022